Year Established :
2019
Total Assets(USD) :
500,000 to 99,999,999
Total Number of Staff :
500-1000
Main Competitive Advantages :
International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages :
We have GMP and DML about our main pharmaceutical raw materials and own core production technique on certain products like fenofibrate.
Business Type :
Trading Company,Manufacturer
R&D Capacity :
OEM,ODM
Annual Turnover(USD) :
500,000 to 99,999,999
Main Sales Markets :
Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Range :
APIs (Fenofibrate, Piroxicam, Ganciclovir, Valacyclovir HCL, etc.)
Veterinary Medicine (Oxytetraycline on oral and injection grade,
Niclosamide, etc)
and Pharmaceutical Package such as Glass Ampoule and Glass Vial (tubular vial and mould vial)